Cibus, Inc. (CBUS) Research

Cibus, Inc. is an agricultural technology company dedicated to innovating and commercializing advanced plant characteristics. The firm's business model involves creating these beneficial traits and then licensing them to seed producers, generating revenue through royalty payments. Cibus primarily concentrates its efforts on two key areas: 1. Boosting Farm Productivity: This involves developing traits that enable farmers to achieve greater crop yields while simultaneously minimizing their need for synthetic crop protection agents and fertilizers. 2. Pioneering Sustainable Components: The company also engineers environmentally responsible ingredient alternatives, offering corporations solutions to replace materials derived from fossil fuels or those whose manufacturing processes significantly contribute to greenhouse gas emissions. The company's headquarters are located in San Diego, California.

Market snapshot

Symbol
CBUS
Price
$1.36
Day change
+5.43%
Market cap
$61.9M
P/E ratio
-8.74x
52-week range
1.09-4.191
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$11.50

Peer companies

  • Acrivon Therapeutics, Inc. Common Stock (ACRV)
  • Biomea Fusion, Inc. (BMEA)
  • CAMP4 Therapeutics Corporation (CAMP)
  • Immunic, Inc. (IMUX)
  • MediciNova, Inc. (MNOV)
  • PMV Pharmaceuticals, Inc. (PMVP)
  • Relmada Therapeutics, Inc. (RLMD)
  • Repare Therapeutics Inc. (RPTX)

Recent insider activity

  • Wichner Craig — A-Award (1047620 shares) on 2026-06-08
  • Wichner Craig — A-Award (894309 shares) on 2026-06-08
  • Finn Mark Terrence — A-Award (77586 shares) on 2026-06-02
  • Moretti August J — A-Award (77586 shares) on 2026-06-02
  • RIGGS RORY B — A-Award (77586 shares) on 2026-06-02

Open Cibus, Inc. (CBUS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.